Gene Therapy — An Inventory
By Karoline Hahn, Senior Consultant, Advanced Therapies at KCR
The landmark approval of two AAV-based gene therapies, one — Luxturna — to treat vision loss due to inherited retinal dystrophy, and the other — Zolgensma — to manage spinal muscular atrophy…
